Impacts of tendering for off-patent medicines on access and costs

Vogler, Sabine; Gombocz, Margit; Zimmermann, Nina

doi:10.1093/eurpub/ckw167.074

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A more or less explicit theme in many of the papers we reviewed is that greater transparency around the R&D costs of individual medicines is necessary for good governance and accountability, and that with such accountability trust -by payers, patients and investors -would be reinforced (see, for example, [69,72,78]).…”

Section: Expected Advantages Of Greater Transparencymentioning

confidence: 99%

Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

2023

View full text Add to dashboard Cite

is a not-for-profit research organisation that helps improve policy and decision making through research and analysis. To learn more about RAND Europe, visit www.randeurope.org. Research IntegrityOur mission to help improve policy and decision making through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behaviour. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

show abstract

Section: Expected Advantages Of Greater Transparencymentioning

confidence: 99%

Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

2023

View full text Add to dashboard Cite

show abstract

Impacts of tendering for off-patent medicines on access and costs

Cited by 1 publication

References 0 publications

Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

Contact Info

Product

Resources

About